Monocyte chemoattractant protein-1 -2518 A/G single nucleotide polymorphism in Chinese Han patients with ocular Behçet's disease

Human Immunology

Volumn 71, Issue 1, 2010, Pages 79-82

  Hou, Shengping ^a   Yang, Peizeng ^a   Du, Liping ^a   Jiang, Zhengxuan ^a   Mao, Liming ^a   Shu, Qinmeng ^a   Zhou, Hongyan ^b   Kijlstra, Aize ^c  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Association; Beh et's disease; Gene polymorphism; MCP 1

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; BEHCET DISEASE; CHINESE; CONTROLLED STUDY; EYE DISEASE; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UVEITIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BEHCET SYNDROME; CHEMOKINE CCL2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 71249118256     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.09.354     Document Type: Article

References (47)

1. Sakane T., Takeno M., Suzuki N., and Inaba G. Behçet's disease. N Engl J Med 341 (1999) 1284-1291
2. Shimizu T., Ehrlich G.E., Inaba G., and Hayashi K. Behçet disease (Behçet syndrome). Semin Arthritis Rheum 8 (1979) 223-260
3. Kaklamani V.G., Vaiopoulos G., and Kaklamanis P.G. Behçet's disease. Semin Arthritis Rheum 27 (1998) 197-217
4. Yang P., Fang W., Meng Q., Ren Y., Xing L., and Kijlstra A. Clinical features of Chinese patients with Behçet's disease. Ophthalmology 115 (2008) 312-318 e314
5. Yang P., Zhang Z., Zhou H., Li B., Huang X., Gao Y., et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res 30 (2005) 943-948
6. Geng L., Ohno S., Wang Y.H., and Higuchi M. Clinical observations on Behçet's disease in Tianjin, China. Jpn J Ophthalmol 29 (1985) 310-314
7. Chung Y.M., Liu J.H., and Tsi S.T. Behçet's disease in Taiwan-a review of 53 cases. Jpn J Ophthalmol 30 (1986) 318-323
8. Muller W., and Lehner T. Quantitative electron microscopy microscopical analysis of leukocyte infiltration in oral ulcers of Behçet's syndrome. Br J Dermatol 106 (1982) 535-544
9. Forrester J.V. Uveitis: Pathogenesis. Lancet 338 (1991) 1498-1501
10. Mantas C., Direskeneli H., Oz D., Yavuz S., and Akoglu T. IL-8 producing cells in patients with Behçet's disease. Clin Exp Rheumatol 18 (2000) 249-251
11. Sayinalp N., Ozcebe O.I., Ozdemir O., Haznedaroglu I.C., Dundar S., and Kirazli S. Cytokines in Behçet's disease. J Rheumatol 23 (1996) 321-322
12. Yosipovitch G., Shohat B., Bshara J., Wysenbeek A., and Weinberger A. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: Correlations with disease activity and severity. Isr J Med Sci 31 (1995) 345-348
13. Laing K.J., and Secombes C.J. Chemokines. Dev Comp Immunol 28 (2004) 443-460
14. Butcher E.C., and Picker L.J. Lymphocyte homing and homeostasis. Science 272 (1996) 60-66
15. Daly C., and Rollins B.J. Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: Therapeutic opportunities and controversies. Microcirculation 10 (2003) 247-257
16. Holtkamp G.M., De Vos A.F., Peek R., and Kijlsta A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells. Clin Exp Immunol 118 (1999) 35-40
17. Verma M.J., Lloyd A., Rager H., Strieter R., Kunkel S., Taub D., and Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res 16 (1997) 1202-1208
18. Bian Z.M., Elner S.G., Strieter R.M., Kunkel S.L., Lukacs N.W., and Elner V.M. IL-4 potentiates IL-1beta- and TNF-alpha-stimulated IL-8 and MCP-1 protein production in human retinal pigment epithelial cells. Curr Eye Res 18 (1999) 349-357
19. Crane I.J., McKillop-Smith S., Wallace C.A., Lamont G.R., and Forrester J.V. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci 42 (2001) 1547-1552
20. Elner S.G., Elner V.M., Bian Z.M., Lukacs N.W., Kurtz R.M., Strieter R.M., and Kunkel S.L. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products. Invest Ophthalmol Vis Sci 38 (1997) 446-455
21. Elner V.M., Burnstine M.A., Strieter R.M., Kunkel S.L., and Elner S.G. Cell-associated human retinal pigment epithelium interleukin-8 and monocyte chemotactic protein-1: Immunochemical and in-situ hybridization analyses. Exp Eye Res 65 (1997) 781-789
22. Wegscheider B.J., Weger M., Renner W., Posch U., Ulrich S., Hermann J., et al. Role of the CCL2/MCP-1 -2518A > G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 11 (2005) 896-900
23. Ahad M.A., Missotten T., Abdallah A., Lympany P.A., and Lightman S. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis. Mol Vis 13 (2007) 388-396
24. Chen Y., Vaughan R.W., Kondeatis E., Fortune F., Graham E.M., Stanford M.R., and Wallace G.R. Chemokine gene polymorphisms associate with gender in patients with uveitis. Tissue Antigens 63 (2004) 41-45
25. Szalai C., Kozma G.T., Nagy A., Bojszko A., Krikovszky D., Szabo T., and Falus A. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 108 (2001) 375-381
26. Karrer S., Bosserhoff A.K., Weiderer P., Distler O., Landthaler M., Szeimies R.M., et al. The -2518 promoter polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 124 (2005) 92-98
27. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 (1999) 344-348
28. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's disease. Lancet 335 (1990) 107-180
29. Zouboulis C.C., Kotter I., Djawari D., Kirch W., Kohl P.K., Ochsendorf F.R., et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. Yonsei Med J 38 (1997) 411-422
30. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol 50 (2005) 297-350
31. Michelson J.B., and Friedlaender M.H. Behçet's disease. Int Ophthalmol Clin 30 (1990) 271-278
32. Idil A., Gurler A., Boyvat A., Caliskan D., Ozdemir O., Isik A., et al. The prevalence of Behçet's disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthal Epidemiol 9 (2002) 325-331
33. Chang H.K., and Kim J.W. The clinical features of Behçet's disease in Yongdong districts: Analysis of a cohort followed from 1997 to 2001. J Korean Med Sci 17 (2002) 784-789
34. Yoshida A., Kawashima H., Motoyama Y., Shibui H., Kaburaki T., Shimizu K., et al. Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 111 (2004) 810-815
35. Mizuki N., Yabuki K., Ota M., Katsuyama Y., Ando H., Nomura E., et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. Tissue Antigens 60 (2002) 396-399
36. Yabuki K., Mizuki N., Ota M., Katsuyama Y., Palimeris G., Stavropoulos C., et al. Association of mica gene and HLA-B* 5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci 40 (1999) 1921-1926
37. Cohen R., Metzger S., Nahir M., and Chajek-Shaul T. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel. Ann Rheum Dis 61 (2002) 157-160
38. Verity D.H., Marr J.E., Ohno S., Wallace G.R., and Stanford M.R. Behçet's disease, the silk road and HLA-B51: Historical and geographical perspectives. Tissue Antigens 54 (1999) 213-220
39. Mizuki N., Ohno S., Ando H., Chen L., Palimeris G.D., Stavropoulos-Ghiokas E., et al. A strong association between HLA-B* 5101 and Behçet's disease in Greek patients. Tissue Antigens 50 (1997) 57-60
40. Kilmartin D.J., Finch A., and Acheson R.W. Primary association of HLA-B51 with Behçet's disease in Ireland. Br J Ophthalmol 81 (1997) 649-653
41. Hou S., Yang P., Du L., Zhou H., Lin X., Liu X., and Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Behçet's disease. Clin Immunol 129 (2008) 170-175
42. Li K., Zhao M., Hou S., Du L., Kijlstra A., and Yang P. Association between polymorphisms of FCRL3, a non-HLA gene, and Behçet's disease in a Chinese population with ophthalmic manifestations. Mol Vis 14 (2008) 2136-2142
43. Lima G., Soto-Vega E., Atisha-Fregoso Y., Sanchez-Guerrero J., Vallejo M., Vargas-Alarcon G., and Llorente L. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus. Hum Immunol 68 (2007) 980-985
44. Gonzalez-Escribano M.F., Torres B., Aguilar F., Rodriguez R., Garcia A., Valenzuela A., and Nunez-Roldan A. MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum Immunol 64 (2003) 741-744
45. Cho M.L., Kim J.Y., Ko H.J., Kim Y.H., Kim W.U., Cho C.S., et al. The MCP-1 promoter -2518 polymorphism in Behçet's disease: Correlation between allele types, MCP-1 production and clinical symptoms among Korean patients. Autoimmunity 37 (2004) 77-80
46. Molestina R.E., Miller R.D., Ramirez J.A., and Summersgill J.T. Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes. Infect Immun 67 (1999) 1323-1330
47. Tuaillon N., Shen D.F., Berger R.B., Lu B., Rollins B.J., and Chan C.C. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 43 (2002) 1493-1498